4.5 Article

Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir

Related references

Note: Only part of the references are listed.
Editorial Material Multidisciplinary Sciences

How a virus travels the world

Josanne H. Verhagen et al.

SCIENCE (2015)

Article Immunology

Rapidly Expanding Range of Highly Pathogenic Avian Influenza Viruses

Jeffrey S. Hall et al.

EMERGING INFECTIOUS DISEASES (2015)

Letter Immunology

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine

Rory D. de Vries et al.

EMERGING INFECTIOUS DISEASES (2015)

Article Multidisciplinary Sciences

Highly Conserved Protective Epitopes on Influenza B Viruses

Cyrille Dreyfus et al.

SCIENCE (2012)

Article Infectious Diseases

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

Julie E. Ledgerwood et al.

LANCET INFECTIOUS DISEASES (2011)

Article Multidisciplinary Sciences

Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development

Mariette F. Ducatez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Jianhua Sui et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)

Review Medicine, Research & Experimental

Medical management of influenza infection

Anne Moscona

ANNUAL REVIEW OF MEDICINE (2008)

Article Multidisciplinary Sciences

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

Ming-Wei Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Letter Medicine, General & Internal

Treatment with convalescent plasma for influenza A (H5N1) infection

Boping Zhou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

Cameron P. Simmons et al.

PLOS MEDICINE (2007)

Review Medicine, General & Internal

Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?

Thomas C. Luke et al.

ANNALS OF INTERNAL MEDICINE (2006)

Review Medicine, General & Internal

Drug therapy - Neuraminidase inhibitors for influenza

A Moscona

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Multidisciplinary Sciences

A DNA transfection system for generation of influenza A virus from eight plasmids

E Hoffmann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)